Blue Marble: Missoula natural chemical manufacturer solicits $1.4M public investment

DAVID ERICKSON | February 24, 2017

article image
A Missoula company that specializes in converting organic waste into natural chemicals is seeking to raise at least $1.4 million from investors to fund operations through the rest of this year. Blue Marble Biomaterials announced on Thursday that it is offering equity shares to the general public through a Regulation A+ offering that is permitted by the Securities and Exchange Commission. The company bills itself as the first zero-waste chemical biorefinery in the United States. Essentially, they replicate processes found in nature to convert organic waste such as used coffee grounds and tomato pulp into natural, non-GMO chemicals that are used as, for example, a synthetic bacon flavoring to be used in a food additive.

Spotlight

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals, Inc. is a team of approximately 200 committed people working with passion to identify meaningful new medicines to advance the care of people with kidney disease. We have assembled a deep concentration of kidney care experts, including nephrologists, renal dietitians, nurses and industry veterans in nephrology. Together, we strive to raise awareness of the kidney disease epidemic, give voice to this underserved population, and help healthcare professionals to improve the care of their patients. In September 2014, the U.S. Food and Drug Administration approved Keryx’s first medicine, Auryxia (ferric citrate) tablets. Keryx established its corporate headquarters in Boston’s innovation district to support the U.S. launch of Auryxia.

OTHER ARTICLES

How Refiners Can Capitalise on the Petrochemical Industry

Article | April 6, 2020

Do you fancy a piece of Petrochemical Pie? As the demand for refined products is falling and demand for petrochemical products is increasing, it is vital that refiners consider petrochemical integration, which offers increased flexibility and a competitive edge. Learn more below about the benefits, considerations and recent projects, and, how the double whammy of the oil price crash and the COVID-19 pandemic is affecting the petrochemical market.

Read More

Developing pre-rig solutions that are greener, safer and more efficient

Article | May 1, 2021

MAY 2021 ///Vol 242 No. 5 FEATURES Developing pre-rig solutions that are greener, safer and more efficient There is an increased focus in the oil and gas sector to look further afield to opportunities presented in deepwater locations. Because of this, finding cost-efficient solutions and overcoming the associated challenges that arise below 1,000 ft will be vital for the success of new activity. Jostein Aleksandersen, Neodrill There is an increased focus in the oil and gas sector to look further afield to opportunities presented in deepwater locations. Because of this, finding cost-efficient solutions and overcoming the associated challenges that arise below 1,000 ft will be vital for the success of new activity. All those currently—and those considering—operating in deepwater fields will have an awareness of the general challenges that are presented at such depths. From considerations relating to vast increases in pressure, to the potential for increased drilling time and days spent offshore, there are several hurdles that follow when operating in what are often challenging well environments. In addition, suitable solutions also must support the industry drive to reduce emissions by offering a more carbon-efficient approach.

Read More

Improving 3D Chemical Visualization of Subsurface Structures

Article | February 19, 2020

A Raman microscope combines a Raman spectrograph and a light microscope to gain chemical and structural information from materials down to the micron scale. Raman spectroscopy observes when the wavelength of light changes as it interacts with a molecule. The different wavelengths seen in Raman scattering can identify and study vibrational, rotational, and bending forces within chemical bonds of a molecule.

Read More

A Coordinated Approach to Chemical Reactivity

Article | March 4, 2020

Atoms are gregarious by nature, escaping a solitary existence by forming chemical bonds with their neighbors. Chemical reactivity, in turn, depends on the degree of atomic “isolation”; a lonely atom will more readily interact and form bonds with others, as compared to its more “coordinated” counterparts that are chemically engaged with other atoms. This coordination concept plays a central role in our understanding of chemical and catalytic activity. What has been lacking to date, however, is a direct and quantitative measurement of the variation in chemical reactivity of atoms having different degrees of coordination.

Read More

Spotlight

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals, Inc. is a team of approximately 200 committed people working with passion to identify meaningful new medicines to advance the care of people with kidney disease. We have assembled a deep concentration of kidney care experts, including nephrologists, renal dietitians, nurses and industry veterans in nephrology. Together, we strive to raise awareness of the kidney disease epidemic, give voice to this underserved population, and help healthcare professionals to improve the care of their patients. In September 2014, the U.S. Food and Drug Administration approved Keryx’s first medicine, Auryxia (ferric citrate) tablets. Keryx established its corporate headquarters in Boston’s innovation district to support the U.S. launch of Auryxia.

Events